The number of patients currently receiving each long-term prophylactic medicine
Case reference FOI2026/02327
Received 8 June 2026
Published 10 September 2026
Request
-
The number of patients currently receiving each long-term prophylactic medicine — lanadelumab, berotralstat, garadacimab, plasma-derived C1-esterase inhibitor (Cinryze and/or Haegarda) — as at the most recent month available.
-
The same counts for each month/quarter from January 2023 onward, if readily held.
-
A breakdown of the current counts by patients' ICB of residence (or first half of postcode / "out-of-area vs in-area"), to whatever level your systems allow without identifying individuals.
For lanadelumab specifically, the split between every-2-week and every-4-week dosing among current patients, if recorded.
Response
1. The number of patients currently receiving each long-term prophylactic medicine — lanadelumab, berotralstat, garadacimab, plasma-derived C1-esterase inhibitor (Cinryze and/or Haegarda) — as at the most recent month available.
36
2. The same counts for each month/quarter from January 2023 onward, if readily held.
Data not held
3. A breakdown of the current counts by patients' ICB of residence (or first half of postcode / "out-of-area vs in-area"), to whatever level your systems allow without identifying individuals.
|
Postcode |
Count of pat |
|
GU34 |
<5 |
|
MK18 |
<5 |
|
NN13 |
<5 |
|
NN16 |
<5 |
|
NN2 |
<5 |
|
OX12 |
<5 |
|
OX13 |
<5 |
|
OX14 |
<5 |
|
OX15 |
<5 |
|
OX16 |
<5 |
|
OX17 |
<5 |
|
OX18 |
<5 |
|
OX2 |
<5 |
|
OX26 |
<5 |
|
OX28 |
<5 |
|
OX29 |
<5 |
|
OX4 |
<5 |
|
OX6 |
<5 |
|
OX7 |
<5 |
|
RG18 |
<5 |
|
SL2 |
<5 |
|
SN11 |
<5 |
|
SN7 |
<5 |
|
SP1 |
<5 |
|
TA1 |
<5 |
|
Grand Total |
32 |
Please note: All values given as <5 are done so to prevent this data from being person identifiable. This is done under section 40 (2) of the FOIA.
For lanadelumab specifically, the split between every-2-week and every-4-week dosing among current patients, if recorded.
Data not held
Documents
This is Oxford University Hospitals NHS Foundation Trust's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.